Status:
UNKNOWN
Functional Lung Imaging in Patients With Respiratory Compromise Undergoing Endobronchial Valve Placement
Lead Sponsor:
Temple University
Collaborating Sponsors:
Respiratory Compromise Institute
Conditions:
Emphysema
Eligibility:
All Genders
40+ years
Brief Summary
Bronchoscopic lung volume reduction (BLVR) using endobronchial valves is effective in improving quality of life in patients suffering from emphysema. BLVR treatment in advanced emphysema requires targ...
Detailed Description
Approach: A novel functional lung imaging, X-ray Velocimetry (XV) technology images the motion of the lungs, determines airway volumes and measures regional lung ventilation during spontaneous breathi...
Eligibility Criteria
Inclusion
- Emphysema
- Undergoing evaluation and planned treatment with BLVR
- Adults, 40 years of age and older
- Consents to functional lung imaging evaluation
- Access to previous chest CT as part of the clinical workup for BLVR
Exclusion
- Known contraindication to BLVR
- Currently receiving mechanical ventilation, intensive or other critical care
- Pregnant women
- Contraindication to ionizing radiation
Key Trial Info
Start Date :
July 5 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05204875
Start Date
July 5 2022
End Date
December 1 2023
Last Update
October 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Temple University Hospital
Philadelphia, Pennsylvania, United States, 19140